Consistently, previous studies have reported the effect of CD73 overexpression on facilitating EMT in other types of tumor, such as gastric cancer, triple-negative breast cancer, ovarian cancer, etc (Lupia et al., 2018; Ma et al., 2019; Xu et al., 2020; Petruk et al., 2021). The gene discussed is NT5E; the disease is ovarian carcinoma.